Annekathrin Reinhardt-Tews

Annekathrin Reinhardt-Tews currently serves as a scientific associate in drug approval at mibe Gmbh Arzneimittel since May 2020. Prior experience includes a role in life science management at ATV GmbH from August 2019 to February 2020, focusing on pharmaceutical management, clinical trial planning, regulatory affairs, and project management. Annekathrin held a postdoctoral position at Martin-Luther-Universität Halle-Wittenberg from April 2010 to June 2019, where involvement in various DFG-funded projects led to extensive research in molecular biology, including work with model organisms and advanced techniques such as fluorescence spectroscopy and chromatin immunoprecipitation. Annekathrin Reinhardt-Tews earned a Ph.D. in Biology from Martin Luther University of Halle-Wittenberg in 2016, following a Diplom in Biology from the same institution in 2010.